The Tie-2 tyrosine kinase receptor, which has been shown to be the first validated tumor vascular response biomarker for VEGF inhibitor efficacy in metastatic colorectal cancer, is expressed mainly on vascular ECs and is essential for vascular maturation (28). Here, VEGFA is linked to metastatic colorectal cancer.